Barbara J. Sitter

The Evolution of High-Throughput Experimentation in Pharmaceutical Development and Perspectives on the Future

Ling Li, Emma McInturff, Ke Wang, 2019, Organic Process Research & Development.

Laboratory Automation for Process R&D

Barbara J. Sitter, Joel M. Hawkins, Teresa W. Makowski, 2003 .

Use of an Iridium-Catalyzed Redox-Neutral Alcohol-Amine Coupling on Kilogram Scale for the Synthesis of a GlyT1 Inhibitor

Yinsheng Zhang, Barbara J. Sitter, Teresa W. Makowski, 2011 .

Evaluation of Kilogram-Scale Sonagashira, Suzuki, and Heck Coupling Routes to Oncology Candidate CP-724,714

Barbara J. Sitter, J. E. Phillips, D. Ripin, 2005 .

Large-Scale Cyclopropanation of Butyl Acrylate with Difluorocarbene and Classical Resolution of a Key Fluorinated Building Block

Barbara J. Sitter, Tao Yu, Tao Yu, 2021, Organic Process Research & Development.

Development of a Nitrene-Type Rearrangement for the Commercial Route of the JAK1 Inhibitor Abrocitinib

Barbara J. Sitter, Brian P. Jones, Nga M. Do, 2020 .

Investigation of Methods for Seven-Membered Ring Synthesis: A Practical Synthesis of 4-Oxo-5,6,7,8-tetrahydro-4H-cyclohepta[b]furan-3-carboxylic Acid

Barbara J. Sitter, Teresa W. Makowski, Brian P. Jones, 2001 .

Early Process Development of an Irreversible Epidermal Growth Factor Receptor (EGFR) T790 M Inhibitor

Barbara J. Sitter, J. McWilliams, N. Keene, 2019, Organic Process Research & Development.